Finally, we observed a clear co-localization of MCT2 with Catalase (a well-known peroxisome marker, Figure 3E) confirming that in PCa MCT2 preferentially localizes at peroxisomes rather than mitochondria in prostate cancer cells [17]. The gene discussed is CAT; the disease is prostate cancer.